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Background: The influenza RNA dependent RNA polymerase synthesizes viral RNA in the nucleus as functional
viral ribonucleoprotein (vRNP) complexes with RNA and nucleoprotein (NP). The N-terminus of NP contains an
unconventional nuclear localization signal (NLS) important for initial vRNP nuclear localization but which also
interacts with various host factors.
Methods: To study the role of the N-terminus of NP aside from NLS function, we generated an N-terminal NP
deletion mutant, del20NLS-NP, encoding the conventional SV40 T-antigen NLS in place of the first 20 amino acids
of NP. We characterized expression, location, and activity of del20NLS-NP compared to wild type NP using reconstituted
vRNP assays, cellular fractionation, Western blotting, and reverse transcription-PCR. We assessed NP nucleotide binding
with gel-shift assays and analyzed NP complexes using 1D blue native gel electrophoresis.
Results: del20NLS-NP is expressed, localized in the nucleus and cytoplasm, and maintains ability to bind nucleic acids.
Despite this, del20NLS-NP exhibits a defect in viral RNA expression exacerbated by increasing vRNA template length.
We find diminished del20NLS-NP high molecular weight complexes in protein extracts; evidence the defect is with
functional vRNP formation. Interestingly, the shortest template, NS vRNA, exhibits a limited defect. However, this is
not due to short template size, but rather activity of the NS protein(s). Expression of NS1 rescues the gene expression
defect primarily at the protein level, a finding consistent with the known role of NS1 as a viral mRNA translational
enhancer. NS1 mutant analysis confirms NS1-RNA binding is not required for the translational enhancement and reveals
the NS1-CPSF30 interaction surface is essential.
Conclusions: del20NLS-NP is a nuclear localized NP mutant able to bind nucleic acids but inefficient for assembly of
functional vRNPs inside the host cell. Our results add to growing evidence the N-terminus of NP plays important roles
aside from vRNP nuclear localization. We demonstrate the utility of this partially functional NP mutant to characterize
the influence of additional proteins on viral gene expression. Our studies reveal the NS1-CPSF30 interaction surface
is required for the ability of NS1 to enhance viral protein translation, supporting a function for this NS1 domain in
the cytoplasm.
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Influenza A viruses cause a highly contagious respiratory
infection, and both seasonal and pandemic strains re-
main a persistent health issue for humans. Influenza
pandemics occurred three times in the 20th century
(1918, 1957 and 1968) and in 2009 the novel H1N1 in-
fluenza (swine flu) became the first influenza pandemic
of the 21st century. Equally troubling are the continued
human infections with the highly pathogenic H5N1
avian influenza (bird flu) in Asia, Europe, and Africa.
This subtype has not yet gained the ability to readily
transmit from human to human, but research has dem-
onstrated this virus is able to evolve increased transmis-
sibility in the ferret model [1,2]. The lack of preparation
for the rapidly spreading novel H1N1 and continued
threats of a possible avian influenza outbreak make it
painfully evident that more knowledge of the basic mo-
lecular activities required for influenza replication is
needed so that new antiviral targets can be identified
and therapies developed.
Influenza is a negative strand RNA virus with eight
vRNA segments. The influenza RNA dependent RNA
polymerase (RdRP) is a three-subunit complex com-
prised of PA, PB1, and PB2, which transcribes and repli-
cates viral RNA in the nucleus. The viral RdRP binds an
RNA panhandle formed by complimentary interaction
between the 5’ and 3’ ends of the viral genome [3,4]. NP
encapsidates each vRNA template and also makes direct
protein contacts with the viral RdRP [5]. Together, the
viral RdRP, NP and each vRNA segment form functional
viral ribonucleoprotein complexes (vRNPs) responsible
for transcription and replication of the viral genome in
the nucleus of the host cell.
The mechanisms of transcription by the viral RdRP are
well characterized. Influenza viral mRNAs are similar to
host messages as they contain both a 5’ cap and 3’ polyA
tail, but these modifications are not acquired through host
cellular processing. The 5’ cap is stolen from nascent cel-
lular mRNAs via a ‘cap-snatching’ mechanism [6]. The
influenza RdRP interacts with host RNA polymerase II
C-terminal domain [7], placing the viral RdRP within the
environment of nascent cellular mRNAs, which acquire
the 5’ cap modification early during transcription. The
PB2 subunit of the influenza RdRP recognizes and binds
cellular capped mRNAs [8] while the PA subunit uses its
intrinsic endonuclease activity to cleave the 5’ capped
RNA [9,10]. The resulting cellular capped RNA fragment
is used by the PB1 subunit of the influenza RdRP as pri-
mer for polymerization and viral mRNA synthesis. Poly-
adenylation of the 3’ end of the viral mRNA occurs by a
‘stuttering’ mechanism, wherein the viral RdRP slips
along five to seven uracil residues approximately 17 to
22 nucleotides from the 5' end of each vRNA template,
resulting in the polymerization of a poly A tail [11,12].Influenza gene expression further requires the splicing
of two viral mRNAs and the nuclear export of spliced
mRNAs (NS2 and M2), intron containing mRNAs (NS1
and M1), and intronless mRNAs (NP,PA, PB1, PB2, HA,
and NA). Evidence suggests a model wherein the resi-
dent RdRP of the vRNP is responsible for transcription,
while a soluble RdRP is responsible for replication from
the vRNA template [13].
NP does not directly participate in the transcriptional
activities described above, but NP is essential for effi-
cient transcription in the host cell as part of the func-
tional vRNP. Replication actively requires NP as NP
encapsidates both the vRNA and cRNA replication prod-
ucts, and NP is required for synthesis of template sized
RNA in vitro [14]. However, NP is more than a struc-
tural RNA binding protein. NP is intricately involved in
promoting viral RNA replication: NP is required for
anti-termination at the polyA addition site during vRNA
to cRNA replication [15], NP and the RdRP stabilize
nascent cRNA and vRNA replication products [16], and
although NP is not essential for RNA replication on
short templates [17], NP protein interaction with the
viral RdRP enhances unprimed RNA initiation in vitro
[18]. The cRNA is then used as template to produce more
vRNA. Viral RNA replication leads to increased vRNA
templates available fo transcription, amplifying production
of viral mRNAs. Thus, in addition to coating the RNA
template, NP plays an integral role in viral RNA replica-
tion and proper viral gene expression.
NP is a multi-functional protein that interacts with a
number of viral and host proteins at various times dur-
ing infection (for review see [19]). The N-terminus of
NP contains an unconventional nuclear localization sig-
nal at amino acids 3-13 (nNLS- SxGTKRSYxxM) critical
for both NP and vRNP nuclear localization [20,21]. Re-
combinant virus encoding mutations within the uncon-
ventional NLS were attenuated with NP localized
primarily to the cytoplasm, resulting in decreased viral
gene expression [22]. The N-terminus also interacts with
host RNA processing factor UAP56, as NP amino acids
1-20 were sufficient to bind UAP56 [23]. UAP56 is a
member of the DEAD-box family of RNA dependent
ATPases and RNA helicases [24], and is involved in cel-
lular mRNA remodeling during mRNA processing and
nuclear export [25]. Experiments with purified NP and
UAP56 proteins in vitro indicate that UAP56 functions
as a chaperone to promote free NP binding to nascent
viral RNA replication products resulting in enhanced
viral RNA synthesis [23,26]. The goal of this study was
to address the role of N-terminal NP interactions in the
context of the host cell. To accomplish this, we designed
a plasmid encoding the conventional NLS from SV40
T-antigen (PKKKRKV) in place of the N-terminal 20
amino acids of NP (del20NLS-NP).
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using transfection to express reconstituted vRNPs in hu-
man embryonic kidney cell line (293 T). We find that
del20NLS-NP is expressed, localized, and binds nucleo-
tides as wild type NP (WT-NP). However, RNA expres-
sion from influenza vRNA templates in the presence of
del20NLS-NP is significantly decreased compared to
WT-NP. Increasing vRNA template length exacerbates
the RNA expression defect. To assess vRNP formation
we analyzed cell protein extracts for NP containing high
molecular weight complexes using 1D blue native gel
electrophoresis and found substantial decrease in high
molecular weight complexes containing del20NLS-NP
compared to WT-NP. These results contribute evidence
that aside from the importance for nuclear localization,
the N-terminus of NP is required for efficient formation
of vRNPs.
Results and discussion
del20NLS-NP is expressed, localized, and binds nucleic
acids as WT-NP
To address the role of N-terminal NP interactions inside
the host cell, we set out to construct a plasmid encoding
an N-terminal NP deletion mutant able to localize to the
nucleus, where viral RNA synthesis and processing occur.
The N-terminal 20 amino acids of NP are sufficient for
interaction with host RNA processing factor UAP56 [23],
but these first 20 amino acids of NP also include an im-
portant, unconventional nuclear localization signal (NLS)
[20-22]. To ensure sufficient nuclear localization of mu-
tant NP proteins, we generated a plasmid to encode the
conventional NLS from SV40 T-antigen (PKKKRKV) at
the N-terminus of NP in place of the N-terminal 20 amino
acids (del20NLS-NP). We also engineered a FLAG epitope
tag at the C-terminus of both WT-NP and del20NLS-NP
for ease of detection and immuno-purification. To ensure
the epitope FLAG tag did not alter NP function in the
context of reconstituted vRNPs, we confirmed WT-NP-
FLAG was as functional as untagged WT-NP for viral
gene expression (GFP-M) in our assay (Figure 1).
To assess expression, localization, and activity of
del20NLS-NP, we transfected human embryonic kidney
cell line (293 T) with plasmids to express reconstituted
vRNPs comprised of the viral vRNA template, viral RdRP,
and either WT-NP, del20NLS-NP, or no NP (vector) nega-
tive control. Expression of the vRNA template was driven
by host RNA polymerase I (pHH21 DNA plasmids), while
expression of mRNAs encoding the viral RdRP subunits
and NP were driven by host RNA polymerase II (pcDNA
DNA plasmids), similar to the system used for expressing
the eight vRNPs required to generate recombinant virus
[27], except only one vRNA segment is expressed at a time
in the host cell so no virus is generated (Figure 1). Nuclear
and cytoplasmic proteins were isolated 48 hours posttransfection. Western blotting with anti-FLAG antibody
confirmed del20NLS-NP was expressed and present in
both the nucleus and cytoplasm, similar to WT-NP
(Figure 2). Hsp90 and Nxf1 served as cytoplasmic and
nuclear localized and loading controls, respectively. To-
gether, the control proteins demonstrated near purity
of the cellular fractionation and allowed confirmation
that del20NLS- NP was expressed and present in the
nucleus as WT-NP (Figure 2). This confirms sufficient
del20NLS-NP is present in the nucleus where viral
RNA synthesis and processing occur to allow analysis
of N-terminal NP nuclear functions aside from nuclear
import.
To ensure that del20NLS-NP maintains RNA binding
activity, we carried out gel shift analysis with immuno
purified NP proteins and biotin labeled single stranded
DNA (ssDNA). The crystal structure of NP reveals a
highly positively charged nucleic acid binding groove for
interaction with viral RNA, which should not be dis-
turbed by deletion of the N-terminal 20 amino acids
[28]. NP RNA binding is blocked by saturation with
single stranded DNA [18]; therefore we incubated the
purified NP proteins with biotin labeled ssDNA corre-
sponding to the 5’ and 3’ ends of the viral RNA. Coo-
massie blue stain of the immuno purified elutant
separated by SDS-PAGE showed no detectable contam-
inating proteins (Figure 3). Both purified WT-NP and
del20NLS-NP, but not the no NP control, shift the biotin
labeled ssDNA, confirming that del20NLS-NP maintains
nucleic acid binding activity as expected (Figure 3). Un-
bound ssDNA was consistently not detected in our no
NP negative control; it is probable unbound ssDNA does
not transfer and stay bound to nitrocellulose membranes
as well as that associated with protein under our assay
and detection conditions.
del20NLS-NP is deficient in RNA expression from vRNA
templates
To investigate the function of del20NLS-NP, we first ex-
amined gene expression from reconstituted vRNPs con-
taining either NS vRNA (853 nucleotides) or M vRNA
(1005 nucleotides) templates. The viral NS and M seg-
ments express both intron containing mRNAs, encoding
NS1 and M1 proteins, and spliced mRNA counterparts,
encoding NS2 (NEP) and M2 proteins, allowing us to
examine gene expression and mRNA processing by spli-
cing in the presence of del20NLS-NP. FLAG N-terminal
tags were fused to the NS and M genes to readily observe
gene expression from the vRNA templates. Our results re-
vealed that del20NLS-NP vRNPs result in a significant de-
crease in FLAG-M1 and FLAG-M2 protein expression,
while FLAG-NS1 and FLAG-NS2 protein expression was
only slightly decreased compared to the expression levels
with WT-NP vRNPs (Figure 4A). Identical results were
Figure 1 Reconstituted vRNPs. Cellular RNA polymerase II drives expression from pcDNA plasmids to produce 5’ capped and 3’ polyadenylated
mRNAs that are translated to express the proteins components of the influenza vRNP and NS proteins as described for each experiment. Cellular
RNA polymerase I drives expression from pHH21 plasmids to produce unmodified full-length influenza vRNAs. Although influenza contains 8
different vRNA segments to form a complete virus, here one vRNA segment is expressed so that virus is not generated. Bottom panels illustrates
WT-NP-FLAG is as functional as WT-NP in reconstituted vRNP assays using GFP-M vRNA template.
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(data not shown). Reverse transcription with oligo dT
and semi-quantitative PCR with gene specific primers
demonstrated the gene expression defect resides at the
level of viral mRNA expression. As with protein expres-
sion, FLAG-M mRNA products were severely de-
creased in the presence of del20NLS-NP while FLAG-
NS mRNA products were decreased, but to a lesser ex-
tent (Figure 4B). Our results show no defect in splicing
in the presence of del20NLS-NP as both FLAG-NS2and FLAG-M2 protein and RNA products were de-
tected (Figure 4).
Gene expression defect is not restricted to M vRNA
templates
We first addressed whether or not the severe defect was
restricted to M expression. We found that both HA vRNA
(1778 nucleotides), a late expressed gene encoding an ex-
ternal protein, and PB1-Glu-Glu vRNA (2333 nucleo-
tides), an early expressed gene encoding an internal
Figure 2 Mutant del20NLS-NP is expressed and localized in the
nucleus and cytoplasm as WT-NP. 293 T cells were transfected with
plasmid mixes to express reconstituted vRNPs containing influenza
RdRP with vRNA templates and either WT-NP, del20NLS-NP, or vector
control as indicated. Cells were fractionated and protein extracts from
both the cytoplasm and nucleus were analyzed by western blot.
Anti-FLAG antibody detects the C-terminal epitope tag of both WT-NP
and del20NLS-NP. Hsp90 is a protein localized to the cytoplasm while
Nxf1 is localized to the nucleus, demonstrating cellular fractionation
with only slight cross contamination of cellular fractions. Shown is a
representative experiment, repeated more than three times.
Figure 3 Mutant del20NLS-NP maintains nucleic acid binding
as WT-NP. A. 293 T cells were transfected with plasmids to express
WT-NP, del20NLS-NP, or vector control as indicated. Total protein
extracts were isolated and subject to immuno purification with
anti-FLAG antibody and elution with FLAG peptide. Elutant was
separated via SDS-PAGE gel and stained with Coomassie blue. B.
Purified NP proteins incubated with biotin labeled single stranded
DNA were resolved via native PAGE gel, transferred to nitrocellulose
membrane, and probed with Streptavidin-HRP. Purified del20NLS-NP and
WT-NP shift the biotin labeled ssDNA as Streptavidin-HRP is detected
with ECL reagents. Unbound biotin labeled ssDNA was not detected.
Shown is a representative experiment, repeated in triplicate.
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expression in the presence of del20NLS-NP (Figure 5).
The PB1 Glu-Glu is not functional in reconstituted vRNP
assays (unpublished observation, LLN) and thus cannot
contribute to vRNP activity. Although our detection
methods for each gene utilized different antibodies and
PCR primers, the severity of the defect appeared variable;
no PB1 protein or RNA was detected with the PB1-Glu-
Glu vRNA template in the presence of del20NLS-NP
above no NP negative control, while HA protein and RNA
were detected with the HA vRNA template, albeit still at
much reduced expression compared to WT-NP.
Increasing vRNA template length exacerbates the defect
in viral RNA expression observed in the presence of
del20NLS-NP
Since the severity of the influenza RNA expression defect
in the presence of del20NLS-NP appeared variable with
different sized templates, we decided to directly address
the role of template length. To do this, we increased the
vRNA template lengths of M and NS by the addition of
GFP. Unlike the FLAG tagged genes, both GFP-M and
GFP-NS protein and mRNA expression were severelyreduced in the presence of del20NLS-NP (Figure 6), sup-
porting the conclusion the defect is exacerbated as vRNA
template length is increased. GFP-M proteins were not de-
tected while GFP-NS proteins were observed in select cells
(Figure 6A). It is unclear why select cells show robust GFP-
NS expression in the presence of del20NLS-NP while the
majority of cells are consistent with the del20NLS-NP
defect and express no GFP-NS. We speculate varied expres-
sion of a factor in these particular cells lessen the
del20NLS-NP defect and allow for functional vRNPs to
form. Our results show most cells expressing components
for reconstituted vRNPs comprised of del20NLS-NP and
GFP-NS vRNA do not express GFP-NS, consistent with a
worsening of gene expression with lengthened template in
the presence of del20NLS-NP.
However HA vRNA (1778 nucleotides) and GFP-M
vRNA (1744 nucleotides) are similar in size yet exhibit
different degrees of inhibition of gene expression in the
presence of del20NLS-NP; while no GFP-M is detected,
some HA is detected (compare Figure 6 with Figure 5).
This varied degree of gene expression revealed in the
presence of del20NLS-NP are consistent with findings
that vRNA segments compete with each other for ex-
pression, with relative expression greatly influenced by
segment length, but also attributed to specific coding re-
gions and UTR sequences [29]. We conclude that
del20NLS-NP results in less viral RNA expression and
that while lengthening the vRNA template exacerbates
the defect observed, other template characteristics, such
Figure 4 Mutant del20NLS-NP is severely defective for gene
expression from M vRNA but less so from NS vRNA. 293 T cells
were transfected with plasmid mixes to express reconstituted vRNPs
containing influenza RdRP with either WT-NP, del20NLS-NP, or no NP,
and either FLAG-NS vRNA or FLAG-M vRNA template, as indicated. A.
Total protein was separated by SDS-PAGE and analyzed by Western
blot. Reconstituted vRNP with WT-NP but no PB1 protein serves as an
additional negative control. Anti-FLAG antibody detects NP-FLAG and
FLAG-NS1, FLAG- NS2, FLAG-M1, and FLAG-M2 proteins. Tubulin serves
as loading control. Shown is a representative experiment, repeated
more than three times. B. Total RNA was isolated, DNase treated, and
1 μg subject to reverse transcription with oligo dT and PCR with gene
specific primers for M and NS as indicated. Asterisks represents aberrant
product observed with FLAG sequence containing templates. Shown is
a representative experiment, repeated in triplicate.
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gene expression.
Little high molecular weight complexes are formed with
del20NLS-NP
To determine if vRNP complexes were formed in the
presence of del20NLS-NP, we separated total protein ex-
tracts expressing reconstituted vRNPs with GFP-NS1ss
(splice site mutation) vRNA templates using 6% 1D
Blue Native PAGE to separate large protein complexes
[30]. After separation, proteins were transferred to nitro-
cellulose and the blot probed with anti-FLAG to detect
WT-NP and del20NLS-NP. We found a decrease in
the amount of NP containing complexes at higher mo-
lecular weight with del20NLS-NP compared to WT-NP
(Figure 7). To confirm these higher molecular weight
complexes seen in the presence of WT-NP were not at-
tributable to NS1 interaction with NP and vRNPs [31-33],
we stripped the blot and further probed with anti-NS1.
GFP-NS1 is expressed with WT-NP containing vRNPs but
less so with del20NLS-NP, as expected, as only some cells
are capable of GFP-NS expression in the presence of
del20NLS-NP (Figure 6). However, GFP-NS1 is primarily
present in lower molecular weight complexes and cannot
account for the higher molecular weight complexes con-
taining WT-NP (Figure 7). These results conclude
that del20NLS-NP is defective in formation of higher mo-
lecular weight complexes seen with WT-NP in cell ex-
tracts. These results are consistent with del20NLS-NP
deficiency in vRNP formation and conclude a role for the
N-terminus of NP independent of the important function
for vRNP nuclear localization [21].
Shortening template length does not alleviate gene
expression defect observed in the presence of del20NLS-
NP
To determine if template length alone could explain
why FLAG-NS was onlyslightly defective for protein ex-
pression, and less defective for RNA expression in the
presence of del20NLS-NP, we created a shortened
FLAG-M template, resulting in a template shorter than
NS vRNA. This shortened FLAG-M vRNA template led
to robust expression of FLAG-M proteins in the pres-
ence of WT-NP but not in the presence of del20NLS-
NP (Figure 8). This result rules out the possibility that
short template length alone explains why NS protein
expression is not inhibited to the same extent as M in
the presence of del20NLS-NP.
Expression of NS1 enhances viral gene expression at the
protein level
Our results with the shortened M vRNA template led
us to hypothesize that a product(s) of the NS segment
compensated for the del20NLS-NP defect. We reasoned
Figure 5 Mutant del20NLS-NP defect is not specific to the M segment. 293 T cells were transfected with plasmid mixes to express recombinant
vRNPs containing influenza RdRP with either WT-NP, del20NLS-NP, or no NP, and either HA vRNA or PB1-GluGlu vRNA template, as indicated. A. Total
protein was separated by SDS-PAGE and analyzed by Western blot. Anti-FLAG antibody detects NP FLAG, anti-HA detects HA, anti-GluGlu detects
PB1-GluGlu, and anti-tubulin detects tubulin and serves as loading control. B. Total RNA was isolated, DNase treated, and 1 μg subject to reverse
transcription with oligo dT and PCR with gene specific primers for HA and PB1-GluGlu; pHH21-HA and pHH21 PB1-GluGlu DNA plasmids serve
as positive controls while pcDNA PB1 untagged DNA plasmid serves as negative control, in addition to no RT. Shown is a representative
experiment, repeated in triplicate.
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tag fused to the N-terminus of NS1 and NS2, encoded
functional FLAG-NS1 and FLAG-NS2 proteins, while
GFP-NS encoded NS proteins that were not functional
due to the 233 amino acid GFP sequence fused to the
N-terminus of NS1 and NS2 (NEP). We hypothesized
that minimal initial expression of FLAG-NS proteins
provide activities that result in near normal levels of
FLAG-NS protein and increased NS RNA in the pres-
ence of del20NLS-NP (Figure 4).
To test this hypothesis, we performed reconstituted
vRNP assays in which the NS1 and NS2 (NEP) proteins
were expressed in addition to the components of the
vRNP by transfection of pcDNA-NS plasmids to ex-
press either NS mRNA which encodes both NS1 and
NS2 (NEP) proteins, or NS1ss mRNA encoding a splice
site mutation resulting in only NS1 proteins produced
(Figure 1). We compared activity of reconstituted vRNPs
with FLAG-M vRNA templates in the presence or absence
of the NS proteins. As hypothesized, addition of NS1 re-
sulted in increased FLAG-M1 and FLAG-M2 protein ex-
pression in the presence of del20NLS-NP (Figure 9A).
Consistent with the reported role of NS1 as a viral mRNA
translational enhancer [34,35], NS1 protein improved M
expression primarily at the protein level in the presence of
del20NLS-NP. RT-PCR revealed FLAG-M mRNA productsremain severely reduced in del20NLS-NP samples com-
pared to WT-NP even in the presence of NS1 (Figure 9B).
Interestingly we observed a greater increase in
FLAG-M mRNA products in samples expressing NS1
compared to samples without NS1 in the presence of
WT-NP but not del20NLS-NP (Figure 9B). NS1 inter-
acts with WT-NP and vRNPs [31-33] and NS1 mu-
tants have altered temporal regulation of influenza
RNA expression [36,37], and therefore it is not sur-
prising that expression of NS1 results in enhanced
viral RNA expression. However, our result demon-
strates an influence of NS1 in the presence of WT-NP
only, suggesting the NS1-NP interaction [33] requires the
N-terminus of NP to effect RNA expression. However, be-
cause there was no significant increase in FLAG-M
mRNA with NS1 in the presence of del20NLS-NP, we at-
tributed the increase in FLAG-M protein expression to
the ability of NS1 to enhance viral mRNA translation
[34,35].
To further verify that NS1 masks the gene expression
defect observed in the presence of del20NLS-NP
through enhancement of influenza mRNA translation, as
opposed to facilitating formation of functional vRNPs or
stimulating RNA synthesis, we examined the ability of
NS1 to alleviate the gene expression defect observed
with the GFP-M vRNA template. With GFP-M vRNA
Figure 6 Mutant del20NLS-NP defect is exacerbated as vRNA template length is increased. 293 T cells were transfected with plasmid
mixes to express recombinant vRNPs containing influenza RdRP with either WT-NP, del20NLS-NP, or no NP, and either GFP-M vRNA (top panels)
or GFP-NS vRNA (bottom panels) template, as indicated. A. GFP protein was visualized with a Nikon Eclipse TS100 (Nikon Intensilight C-HGFI for
fluorescence). B. Total RNA was isolated, DNase treated, and 1 μg subjected to reverse transcription with oligo dT and PCR with gene specific
primers for M and NS. Shown is a representative experiment, repeated in triplicate.
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presence of del20NLS-NP, in contrast to FLAG-M
vRNA template, where RNA and proteins products
were reduced but clearly present (compare Figure 6
with Figure 4). If functional vRNP formation were sta-
bilized or RNA synthesis were enhanced by the pres-
ence of NS1, we would expect to observe at least some
alleviation of the gene expression defect at the protein
level due to increased mRNA expression. However, if
translation of existing mRNAs were enhanced, we
would not expect to observe increased GFP-M protein
expression, as no GFP-M mRNAs would be present for
NS1 to act on and enhance translation. Indeed we ob-
serve the latter, with NS1 addition resulting in in-
creased FLAG-M protein expression but not GFP-M
protein expression (Figure 10). This data confirms our
conclusion that NS1 masks the gene expression defect
observed in the presence of del20NLS-NP via its ability
to enhance viral mRNA translation [34,35]. NS1 also
results in increased PA protein expression, demonstrat-
ing the phenomenon is not restricted to M protein ex-
pression (Figure 11). The FLAG-PA produced from the
vRNA template is not functional in reconstituted vRNP
assays (unpublished observation, LLN) and thus cannot
contribute to vRNP activity.NS1-CPSF30 interaction surface is required to enhance
viral translation
To demonstrate the utility of del20NLS-NP to characterize
the effect of additional proteins on influenza gene expres-
sion, we analyzed an NS1 RNA binding mutant and two
NS1 CPSF30 binding site mutants. We found that ex-
pression of wild type NS1 or RNA binding deficient
NS1 protein, NS1 R38A, resulted in increased FLAG-PA
protein expression in the presence of del20NLS-NP
(Figure 11). This is despite decreased NP and del20NLS-
NP expression in the presence of both wild type NS1 and
NS1 R38A due to NS1 interaction with CPSF30 and sub-
sequent inhibition of cellular mRNA processing [38]. Ex-
pression of NP (and the polymerase subunits) in the
reconstituted vRNP system is driven by host RNA poly-
merase II (Figure 1) and dependent on CPSF30 for proper
3’ end processing of NP (and polymerase subunit) encod-
ing mRNAs. Our results are consistent with NS1 activity
of viral translational enhancement, which does not require
NS1 RNA binding [35] and prove activities of NS1 that re-
quire RNA binding, such as inhibition of RNase L [39] or
interaction with host RNA helicase A [40], are not re-
quired to observe increased FLAG-PA protein expres-
sion in the presence of del20NLS-NP. While NS1 RNA
binding is dispensable for increased FLAG-PA protein
Figure 8 Gene expression from shortened M vRNA template
remains defective in the presence of del20NLS-NP. 293 T cells
were transfected with plasmid mixes to express recombinant vRNPs
containing influenza RdRP with either WT-NP, del20NLS-NP, or no
NP, and FLAG-M short vRNA template. Total protein was separated
by SDS-PAGE and analyzed by Western blot. Anti-FLAG antibody
detects NP FLAG and FLAG- M products. Asterisk represents FLAG
detected product of unconfirmed identity. Anti-tubulin detects
tubulin and serves as a loading control. Shown is a representative
experiment, repeated in triplicate.
Figure 7 del20NLS-NP does not form high molecular weight
complexes. 293 T cells were transfected with plasmid mixes to
express recombinant vRNPs containing influenza RdRP with either
WT-NP, del20NLS-NP, or no NP, and GFP-NS1ss vRNA templates. Total
protein extracts were separated on TBE (native) 6% PAGE facilitated by
coomassie blue. Proteins were transferred to nitrocellulose and probed
with anti-FLAG antibody to detect NP proteins and anti- NS1 antibody
to detect NS1 proteins.
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tants in the CPSF30 interaction domain, NS1 W187R
and NS1 G184R, do not result in improved protein ex-
pression of FLAG-PA (Figure 11), this is despite the in-
crease in del20NLS-NP expression compared to samples
expressing wild type NS1 or NS1 R38A proteins. In-
creased expression of del20NLS-NP proteins are expected,
as NS1 G184R and NS1 W187R mutants are unable to in-
hibit cellular 3’ end processing. These results reveal that
the CPSF30 binding domain of NS1, required to inhibit
cellular mRNA polyadenylation in the nucleus, is essential
for enhanced viral translation, an activity that occurs in
the cytoplasm. Future experiments will address whether
interaction with CPSF30 is required or if this NS1 inter-
action surface is involved in other important interactions.
We speculate the latter will likely prove to be the case as
translation occurs in the cytoplasm, while CPSF30 resides
in the nucleus. Further, there is evidence that this same
NS1 interaction surface is involved in viral virulence by an
unknown mechanism that does not involve the IFNsystem [41]. Our results suggest this NS1 interaction sur-
face is not only an antiviral target in the nucleus [42], but
inhibition in the cytoplasm should also prove effective.
Conclusion
We have two main conclusions. First we validate the sig-
nificance of the N-terminus of NP aside from vRNP and
NP nuclear import [20-22]. We did this by replacing the
N-terminus of NP with the conventional NLS from SV40-
T antigen to generate a nuclear localized N-terminal NP
deletion mutant. Using reconstituted vRNP assays, we
Figure 9 Expression of NS1 protein rescues gene expression
defect observed with mutant del20NLS-NP at protein level.
293 T cells were transfected with plasmid mixes to express
recombinant vRNPs containing influenza RdRP with either WT-NP,
del20NLS-NP, or no NP, and FLAG-M vRNA as template in the presence
or absence of NS1 and NS2 or NS1 only as indicated. A. Total protein
was separated by SDS-PAGE and analyzed by Western blotting with
anti-FLAG antibody to visualize FLAG-M products. Anti-tubulin detects
tubulin and serves as a loading control. B. Total RNA was isolated,
DNase treated, and 1 μg subject to reverse transcription with oligo dT
and PCR for 23 cycles with either M or NS gene specific primers.
Asterisk represents aberrant product observed with FLAG-M vRNA
templates. Shown are representative experiments, repeated
in triplicate.
Figure 10 GFP-M protein expression is not recovered by
presence of NS1. 293 T cells were transfected with plasmid mixes
to express recombinant vRNPs containing influenza RdRP with either
WT-NP, del20NLS-NP, or no NP, and either GFP-M vRNA or FLAG-M
vRNA in the presence or absence of NS1 as indicated. Total protein
was separated by SDS-PAGE and analyzed by Western blotting.
Anti-Udorn antibody detects NP and M1 products. Anti-NS1 detects
NS1. Anti-tubulin detects tubulin and serves as a loading control.
Shown is a representative experiment, repeated in triplicate.
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binding but displayed diminished influenza RNA expres-
sion, exacerbated by vRNA template length. 1D blue na-
tive gel electrophoresis of total protein extracts from
transfected 293 T cells expressing reconstituted vRNPs
with GFP-NS1ss vRNA templates found little del20NLS-
NP in higher molecular weight complexes, compared to
WT-NP. Our results support a defect in functional vRNPformation with del20NLS-NP, resulting in decreased RNA
and protein expression from the vRNA template. From
characterization of this nuclear localized NP mutant we
can conclude the N-terminus of NP plays a role in func-
tional vRNP formation, independent of any role in vRNP
nuclear localization.
The second conclusion asserts the usefulness of
del20NLS-NP as a tool to characterize regulation of in-
fluenza gene expression. The fact that this NP mutant
displays partial function facilitates study of the influence
of NS1, NS2/NEP, and other factors on influenza RNA
and protein expression. Unlike WT-NP, del20NLS-NP
provides clear observable differences in viral protein ex-
pression in the presence or absence of additional factors
in reconstituted vRNP assays. This conclusion is under-
scored by our confirmation that NS1 functions to en-
hance influenza mRNA translation [34,35]. Further, NS1
mutant analysis reveals the NS1-CPSF30 interaction sur-
face is important for this cytoplasmic function of NS1
and could prove an effective cytoplasmic antiviral target.
Methods
Cells
Human embryonic kidney (293 T) cell line was pur-
chased from ATCC and maintained in a water-jacketed
incubator at 37°C with 5% CO2 output.
Plasmids
pcDNA plasmids expressing Influenza A Udorn mRNA
to encode PA, PB1, PB2, NP, NS, NS1ss, NS1ss R38A,
NS1ss W187R, NS1ss G184R proteins, and pHH21
Figure 11 NS1 RNA binding is not required for rescue but
CPSF30 interaction domain is essential. 293T cells were
transfected with plasmid mixes to express recombinant vRNPs
containing influenza RdRP with either WT-NP, del20NLS-NP, or no
NP, and FLAG-PA vRNA as template in the presence or absence of
NS1 and NS1 mutants as indicated. Total protein was separated
by SDS-PAGE and analyzed by Western blotting with anti-FLAG
antibody to visualize FLAG-PA products. Anti-NS1 detects NS1.
Anti-tubulin detects tubulin and serves as a loading control. Shown
is a representative experiment, repeated in triplicate.
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vRNAs, were gifts from the Krug laboratory. The
pcDNA plasmid expressing WT-NP encoding a C-
terminal Flag epitope tag was constructed using PCR
(primers from Operon). In addition to proper restriction
enzymes sites, the 5’ primer encoded the start codon
and the first amino acids of NP while the 3’ primer
encoded the last amino acids of NP followed by a short
glycine linker and the FLAG epitope tag (DYKDDDDK)
prior to the stop codon. The del20NLS-NP was con-
structed in a similar manner using the same 3’ primer
but in this case the 5’ primer encoded the conventional
NLS from SV40 T antigen (PKKKRKV) in between the
start codon and NP codon 21. The PCR products were
digested with EcoRI and XbaI and ligated into pcDNA
vector. pHH21 Flag-NS vRNA, Flag-M vRNA, GFP-M
vRNA, GFP-NS vRNA, GFP-NS1ss vRNA and Flag-PA
vRNA, were constructed by two step PCR. The first step
resulted in two DNA fragments, one encoding the anti-
sense for the 5’ UTR–start codon and tag (FLAG or
GFP) fused with the 5’ portion of the viral gene, the sec-
ond encoding an overlapping region of the 5’ portion of
the viral gene through the 3’ end. The two DNA frag-
ments were used as templates in the second PCR step
with BsmB1 5’common UTR and BsmB1 3’common
UTR primers to produce the entire fusion coding se-
quence. The DNA insert was digested with BsmB1 and
inserted into pHH21 so that the vRNA was expressedfrom the plasmid. The pHH21 PB1- GluGlu vRNA plas-
mid was made in a similar fashion except the tag was
engineered at the 3’ of the PB1 gene. The FLAG-M short
vRNA plasmid was made by digestion of the pHH21-
FLAG-M vRNA plasmid with NcoI and ligation of the
larger DNA fragment, resulting in a construct missing
~250 nucleotides within the intron sequence. All newly
constructed plasmids were sequenced at the CSUPERB
Sequencing Facility at San Diego State University to con-
firm successful plasmid construction.
Antibodies
Anti-Udorn and anti-NS1 antibody were kind gifts
from the Krug laboratory and used at a 1:1000 dilution
for Western blotting. Anti-FLAG antibody was
purchased from Stratagene and used as per manu-
facturer’s suggestion. Anti-Glu-Glu, anti-Nxf1, anti-
Hsp90, and anti-Tubulin were purchased from Abcam
and used as per manufacturer’s suggestion. Secondary
HRP coupled anti-Rabbit, anti-Mouse, and anti-Goat
were purchased from Pierce and used at a 1:10,000
dilution.
DNA transfection
293 T cells were grown to approximately 70% con-
fluency in either 10 cm or 6-well plates depending on
experiment. Plasmid DNA was purified using Qiagen
QIAprep spin plasmid purification kits as per the manu-
facturer’s protocol. DNA with pcDNA plasmids to ex-
press either WT-NP, del20NLS-NP, or vector, alone or
in the presence of PB1, PB2, PA, and along with the ap-
propriate pHH21 plasmid(s) to express vRNA tem-
plates, was mixed with Mirus transfection reagent at a
1:3 ratio of DNA to reagent and cells were transfected
as per the manufacturer’s protocol. 48 hours post trans-
fection cells were washed with 1X PBS, collected, and
pelleted by centrifugation.
Isolation of cytoplasmic and nuclear proteins
Cell pellets were washed twice with 5 volumes of the cell
pellet in Reticulocyte Standard Buffer (RSB: 10 mM Tris
HCl pH 7.5, 10 mM KCl, 1.5 mM MgCl2). Cells were
then resuspended in RSB at 10× the volume of the cell
pellet and incubated on ice for 10 minutes. NP-40 was
added at a final concentration of 0.2 % to disrupt plasma
membranes. Visual inspection of the cells before and
after addition of NP-40 ensured that the plasma mem-
branes were disrupted, but that the nuclei remained in-
tact. Nuclei were pelleted by centrifugation at 300 g for
8 minutes at 4°C. The cytoplasmic extract was collected
and the nuclear pellet was resuspended in Dignam buffer
C without glycerol (20 mM HEPES pH 7.9, 0.42 M
NaCl, 1.5 mM MgCl2, 0.2 mM EDTA) to release nuclear
molecules. Both cytoplasmic and nuclear extracts were
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10 minutes at 4°C. An equal amount of 20 mM HEPES
pH 7.9, 0.2 mM EDTA was added to the nuclear extract
to reduce the total NaCl and MgCl2 concentrations. All
buffers used contained protease inhibitors (Pierce).
Isolation of total protein and RNA
To isolate total protein extracts, cell pellets were resus-
pended in 10 volumes of the cell pellet in RIPA Lysis
Buffer (25 mM HCl pH 7.6, 150 mM NaCl, 1% deoxy-
cholate, 0.1% SDS) with protease inhibitors. Cells were
lysed and genomic DNA sheared using Fisher Scientific
Sonic Dismembrator for 10 pulses at 30%, output 3-4.
Total RNA was isolated using Trizol (Invitrogen) ac-
cording to the manufacturer’s protocol. RNA was quan-
tified and evaluated for purity by taking OD260 and
OD280 readings in duplicate on the NanoDrop ND1000
Nanospectrophotometer (Thermo Fisher Scientific).
SDS-PAGE and Western Blot analysis
Protein extracts were separated by SDS-10%PAGE. Pro-
teins were transferred to nitrocellulose using a Fisher
semi- dry blot apparatus and probed with primary and
HRP-conjugated secondary antibodies as indicated.
Pierce ECL reagents were used to detect HRP conju-
gated secondary antibody. Blots were developed using
the Chemi-Hi setting on the ChemiDoc XRS (BioRad)
System and digital images were obtained using Quantity
One software.
GFP detection
GFP was visualized with a Nikon Eclipse TS100 (Nikon
Intensilight C-HGFI for fluorescence) inverted micro-
scope and images captured with the Nikon DS-Qi1Mc
camera with NS Elements software.
Reverse transcription – PCR
Prior to reverse transcription RNA OD was taken in du-
plicate to ensure use of equal concentrations of total
RNA, and RNA was analyzed by gel electrophoresis to
ensure no RNA degradation. RNA was first treated with
RNase-free DNase (Promega) to degrade any contamin-
ating plasmid DNA. 1 μg total RNA was subject to re-
verse transcription using oligo dT. Promega reverse
transcription system was used as per the manufacturer’s
protocol with the modification of increasing the reverse
transcription time to 59 minutes to facilitate complete
first strand cDNA synthesis. Reverse transcription
reactions were aliquot from a master mix to ensure all
samples received equivalent AMV-RT enzyme. Primers
used in semi-quantitative PCR were as follows: M
detection: (5’M) GCCTTCTGACCGAGGTCG, (3’M)
CGATCAAGAATCCAC NS detection: (5’NS) GGATT
CCAACACTGTG, (3’NS) CGATGTTTAGACCG HAdetection: (5’HA) GTCGCTCTGGAGAACCAACATA
CAA, (3’HA) ACAAGGGT GTTTTTAATTACTAATA
PB1-Glu-Glu detection: (5’PB1) GGGAAAGGATAC
ATGAACGAAAGT, (3’GluGlu) CTCCATTGGCATG
TACTC PCR products were separated on 1% agarose
gels. Gels were analyzed with the UV setting on the
ChemiDoc™ XRS (BioRad) System and digital images
were captured using Quantity One software.
Isolation of total protein extract for native gel and IP
assays
Cell pellets were resuspended in 1 mL of sonication
buffer (10 mM Tris HCl pH 7.5, 100 mM NaCl,
2.5 mM MgCl2, 0.5% Triton X-100). Cells were lysed
using a Fisher Scientific Sonic Dismembrator for 30
pulses at 30%, output 3-4. Sonicated materials were
loaded onto 1 mL of 30% sucrose cushion (30% sucrose,
10 mM Tris HCl pH 7.5, 10 mM NaCl, 2.5 mM MgCl2)
and centrifuged at 4000 g for 15 minutes at 4°C to clar-
ify the total protein extract. Total protein extract was
used for 1D blue native gel electrophoresis or immuno
purification.
Immuno purification
Total protein extracts were incubated with anti-FLAG
antibody (Stratagene) (1:50) for 1 hour at 4°C at which
point PA/G sepharose beads washed in sonication buffer
with protease inhibitors were added and incubation was
continued at 4°C overnight. The samples were then spun
for 1 minute at 1000 g at 4°C. For gel shift assays beads
were washed 6 times. After washes in sonication buffer,
beads were resuspended in 0.00125 mM 3X FLAG Pep-
tide and incubated overnight at 4°C. Samples were then
centrifuged at 1000 g for 1 minute. Supernatant, contain-
ing purified proteins, was collected. Samples were sepa-
rated by SDS-PAGE and stained with Coomassie Blue.
Gel shift
Purified protein preparations were incubated with 50 nu-
cleotide long single stranded DNA modified with 5’ biotin
for detection, and corresponding to the sequence of the 5’
and 3’ ends of the viral RNA (Biotin-AGCAAA
AGCAGGGTGACAAAGACATGATAAAAAACACCC
TTGTTTCTACT). After the incubation period the com-
plexes were separated on a TBE (native) 8% PAGE,
transferred to a nitrocellulose membrane using a Fisher
semi-dry blot apparatus, and biotin labeled DNA was
detected by incubation of the membrane with HRP
conjugated streptadivin. Pierce ECL reagents were used
to visualize HRP conjugated streptadivin. Blots were de-
veloped using the Chemi-Hi setting on the ChemiDoc™
XRS (BioRad) system and digital images were obtained
using Quantity One software.
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Total protein extracts were separated on 6% PAGE TBE
(native) facilitated by coomassie blue [40]. Gel was run
at 4°C until denatured molecular markers of at least
72 kDa ran off the gel. Further characterization is re-
quired to obtain the exact size(s) and molecular identity
of other components present in the WT-NP containing
higher molecular weight complexes observed. Proteins
were transferred to nitrocellulose using a Fisher semi-dry
blot apparatus. Blots were probed with primary and HRP-
conjugated secondary antibodies as indicated. Pierce ECL
reagents were used to detect HRP conjugated secondary
antibody. Blots were developed using the Chemi-Hi set-
ting on the ChemiDoc™ XRS (BioRad) system and digital
images were obtained using Quantity One software.
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